Cooper Companies | COO - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 2.94M 2026-03
Align Technology USD 71.62M 1000 2026-06
AtriCure USD 50.64M 7K 2026-06
Bausch Health Companies USD 373.9M 436K 2026-06
Baxter International USD 517M 549K 2026-06
Bayer EUR 982.42M 0 2026-06
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.11M 14K 2026-03
Dentsply International USD 199.2M 1.1M 2026-06
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 577M 3.7M 2026-03
Globus Medical USD 135.67M 611K 2026-03
Haemonetics USD 45.47M 1.36M 2026-06
Inogen USD 23K 0 2023-12
Insulet USD 69.35M 87K 2026-06
Integra LifeSciences USD 77.78M 39K 2026-06
Intuitive Surgical USD 354.16M 1.01M 2026-06
J&J USD 2.41B 1.35M 2026-03
Medtronic USD 1.28B 3.19M 2026-03
Merit Medical Systems USD 59.71M 55K 2026-06
Novartis USD 1.91B 60K 2026-03
ResMed USD 145.06M 45.78M 2026-06
STAAR Surgical USD 50.12M 343K 2026-06
Steris USD 98.07M 72K 2026-03
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.54M 1.04M 2026-06
Teleflex USD 44.26M 70K 2026-03
Utah Medical Products USD 3.18M 2K 2026-03
Zimmer Biomet Holdings USD 193.4M 2.1M 2026-06